- 13 July 2020
- Transport / Logistics Services
Angela Hwang has been appointed to the board of UPS board of directors, effective immediately.
Hwang, 54, is also a member of Pfizer’s executive team – she is Group President of the Pfizer Biopharmaceuticals Group that brings in around 80% of the revenues of the company. As Group President she leads more than 26,000 staff and is responsible for selling over 600 medicines and medical products to patients and hospitals around the world.
“The UPS Board engaged in a thorough search and evaluation to find the right candidate for this role,” said UPS Executive Chairman of the Board David Abney. “Angela’s expertise in the healthcare sector will bring added talent to our Board as we oversee the company’s strategic growth efforts in this area.”
“Angela is an outstanding, proven leader who brings added healthcare and global management experience to our Board,” said UPS Chief Executive Officer Carol Tome. “We couldn’t be more thrilled to welcome Angela to the UPS Board of Directors during this time when UPS continues to expand its leadership in the healthcare logistics space, launching new healthcare services for UPS customers.”